妙佑医疗国际的方法

在妙佑医疗国际,心脏医生(心脏科医生)、心脏外科医生(心血管外科医生)与其他医疗护理专业人员通力协作,对心律失常患者进行评估和治疗。这种协作方式意味着医疗护理团队通常可以在 2 至 3 天内完成个性化治疗方案的制定。

专长与排名

妙佑医疗国际的医生和医疗护理专业人员在诊断和治疗心律不齐方面具有丰富经验。每年有 2000 多位患者在妙佑医疗国际植入起搏器。

全美公认的专业实力

妙佑医疗国际各院区在心脏病学和心血管外科方面的专业技术享誉全国:

  • 妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际亚利桑那州凤凰城/斯科茨代尔院区和妙佑医疗国际佛罗里达州杰克逊维尔院区均在《美国新闻与世界报道》心脏和心脏手术“最佳医院”排名中名列前茅。
  • 在《美国新闻与世界报道》2023–2024 年“最佳儿童医院”评选中,位于罗切斯特的妙佑医疗国际儿童中心在明尼苏达州以及爱荷华、明尼苏达、北达科塔、南达科塔和威斯康星州五州地区均荣获第一。

妙佑医疗国际非常重视合作式医疗护理,明尼苏达州、亚利桑那州和佛罗里达州院区的专科医生会与其他院区及妙佑区域医疗系统的同事密切交流。

了解更多关于妙佑医疗国际心血管外科心血管内科的专业知识和排名。

位置、旅行和住宿

Mayo Clinic 在亚利桑那州的凤凰城和斯克茨戴尔、佛罗里达州的杰克逊威尔,以及明尼苏达州的罗切斯特都有主要院区。Mayo Clinic 健康系统在几个州拥有十几个工作地点。

有关参观 Mayo Clinic 的更多信息,请在下面选择您的位置:

费用与保险

妙佑医疗国际与数百家保险公司合作,是数百万人的网络内医疗服务提供者。

大多数情况下,来妙佑医疗国际就诊不要求医生的转诊证明。部分保险公司有转诊要求,或对某些医疗护理有其他要求。所有约诊均根据医疗需求安排优先顺序。

详细了解在妙佑医疗国际约诊的信息。

请联系您的保险公司,核实承保范围,并在就诊前获得所需要的任何授权。您保险公司的客户服务号码通常印在保险卡背面。

临床试验

探索 Mayo Clinic 的研究 测试新的治疗、干预与检查方法,旨在预防、检测、治疗或控制这种疾病。

Nov. 03, 2023
  1. Pacemaker. American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/pacemaker. Accessed Dec. 13, 2022.
  2. Pacemakers. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/pacemakers. Accessed Dec. 13, 2022.
  3. How the healthy heart works. American Heart Association. https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/how-the-healthy-heart-works. Accessed Dec. 13, 2022.
  4. All about heart rate (pulse). American Heart Association. https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure/all-about-heart-rate-pulse. Accessed Dec. 19, 2022.
  5. Mulpuru SK, et al. Cardiac pacemakers: Function, troubleshooting, and management: Part 1 of a 2-part series. Journal of the American College of Cardiology. 2017; doi:10.1016/j.jacc.2016.10.061.
  6. Living with your pacemaker. American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/living-with-your-pacemaker. Accessed Dec. 13, 2022.
  7. Devices that may interfere with ICDs and pacemakers. American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/devices-that-may-interfere-with-icds-and-pacemakers. Accessed Dec. 13, 2022.
  8. Link MS. Permanent cardiac pacing: Overview of devices and indications. https://www.uptodate.com/contents/search. Accessed Dec. 13, 2022.
  9. Madhavan M, et al. Advances and future directions in cardiac pacemakers: Part 2 of a 2-part series. Journal of the American College of Cardiology. 2017; doi:10.1016/j.jacc.2016.10.064.
  10. Libby P, et al., eds. Diagnosis and management of acute heart failure. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Dec. 13, 2022.
  11. Hutchison K, et al. Ethics and the cardiac pacemaker: More than just end-of-life issues. Europace. 2018; doi:10.1093/europace/eux019.
  12. Ami TR. Allscripts EPSi. Mayo Clinic. Dec. 21, 2022.
  13. Lee JZ, et al. Leadless pacemaker: Performance and complications. Trends in Cardiovascular Medicine. 2018; doi:10.1016/j.tcm.2017.08.001.
  14. Noseworthy PA (expert opinion). Mayo Clinic. June 28, 2021.
  15. Leadless pacing systems: Risk of major complications related to cardiac perforation during implantation ⸺ Letter to health care providers. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/letters-health-care-providers/leadless-pacing-systems-risk-major-complications-related-cardiac-perforation-during-implantation. Accessed Dec. 19, 2022.
  16. Mankad R (expert opinion). Mayo Clinic. Nov. 22, 2021.
  17. Cha YM (expert opinion). Mayo Clinic. April 30, 2023.
  18. Stühlinger M, et al. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices. Europace. 2022; doi:10.1093/europace/euac040.